Lung Cancer Treatment Advances in 2022

Authors

Fawzi Abu Rous, Henry Ford HealthFollow
Eric K. Singhi
Arthi Sridhar
Muhammad Salman Faisal
Aakash Desai

Recommended Citation

Abu Rous F, Singhi EK, Sridhar A, Faisal MS, and Desai A. Lung Cancer Treatment Advances in 2022. Cancer Invest 2022; 1-20.

Document Type

Article

Publication Date

8-29-2022

Publication Title

Cancer investigation

Abstract

The therapeutic landscape of lung cancer treatment is changing rapidly, and new data was presented at the recently concluded American Society of Clinical Oncology 2022 (ASCO22) meeting. We highlight studies of clinical relevance that represent significant updates in the current management of non-small cell lung cancer (SCLC) and small cell lung cancer (NSCLC). We summarize the updates in early-stage NSCLC, mutated and non-mutated advanced NSCLC as well as small cell lung cancer (SCLC), and discuss these advances in the context of the current clinical standard of care.

PubMed ID

36036470

ePublication

ePub ahead of print

First Page

1

Last Page

20